For: | Kramer CS, Dimitrakopoulou-Strauss A. Immuno-Imaging (PET/SPECT)-Quo Vadis? Molecules 2022;27:3354. [PMID: 35630835 DOI: 10.3390/molecules27103354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Allen KJH, Jiao R, Li J, Beckford-Vera DR, Dadachova E. In Vitro and In Vivo Characterization of 89Zirconium-Labeled Lintuzumab Molecule. Molecules 2022;27:6589. [PMID: 36235126 DOI: 10.3390/molecules27196589] [Reference Citation Analysis] |
2 | Filippi L, Evangelista L, Sathekge MM, Schillaci O. ImmunoPET for prostate cancer in the PSMA era: do we need other targets? Clin Transl Imaging. [DOI: 10.1007/s40336-022-00520-w] [Reference Citation Analysis] |